ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
L01DB01 | G | Doxorubicin HCl - 50mg/25ml | 7726 | 187091/13 | DOXO-CELL | 50mg/25ml | 1 x 25ml | Injectable solution | Infusion | Drugstore 3U S.A.R.L. | Thymoorgan Pharmazie GmbH | Germany | 1,794,030 L.L | 23.08 | B | Stadapharm GmbH | Germany | 2/5/2024 | 0 |
ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
L01DB01 | G | Doxorubicin HCl - 50mg/25ml | 10684 | 164119/1 | DOXORUBICINA TEDEC | 50mg/25ml | 1 | Injectable concentrate for solution | Infusion | Mediterranean Pharmaceutical Company | GP-Pharm, SA | Spain | 2,015,764 L.L | 23.08 | B | Meiji Pharma Spain SA | Spain | 2/5/2024 | 0 |
L01DB01 | G | Doxorubicin HCl - 2mg/ml | 2479 | 135397 | DOXORUBICINE EBEWE | 50mg/25ml | 1 x 25ml | Injectable concentrated solution | Infusion/IV | Khalil Fattal & Fils S.A.L. | Fareva Unterach GmbH | Austria | 1,804,780 L.L | 23.08 | B | 2/5/2024 | 0 |